Korean colorectal cancer screening guidelines for asymptomatic, average-risk adults: the 2025 revision
- Author:
EunKyo KANG
1
;
Jae Myung CHA
;
Seo Young KANG
;
Kiheon LEE
;
Su Young KIM
;
Younghoon KIM
;
An Na SEO
;
Hyo-Jin KANG
;
Jong Keon JANG
;
Kwang-Pil KO
;
Aesun SHIN
;
Dae Kyung SOHN
;
Youngki HONG
;
Eun-Jung CHO
;
Minje HAN
;
Soo Young KIM
;
Hyeon Ji LEE
;
Chang Kyun CHOI
;
Mina SUH
Author Information
- Publication Type:Practice guideline
- From:Journal of the Korean Medical Association 2026;69(3):268-280
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Purpose:To develop the 2025 update to the Korean colorectal cancer (CRC) screening guidelines by systematically evaluating recent evidence, integrating domestic data, and addressing changes since the 2015 guideline revision, thereby providing an evidence-based standard for clinicians and policymakers.
Methods:A multidisciplinary committee developed the guidelines using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. The process included formulation of three key questions addressing screening efficacy, diagnostic accuracy, and optimal screening age and interval. A systematic review of international guidelines and primary literature was conducted, yielding 327 eligible studies. In addition, a utility-based analysis using a Markov model was performed to determine optimal screening ages and intervals.
Results:The evidence synthesis identified high-certainty evidence supporting the use of the fecal immunochemical test (FIT) for reducing CRC mortality and moderate-certainty evidence for colonoscopy. Evidence for computed tomographic colonography (CTC) and stool DNA testing was rated as very low certainty. Based on the evidence review and cost-utility analysis, the committee conditionally recommends CRC screening for asymptomatic, average-risk adults aged 45–74 years using either colonoscopy every 10 years or FIT every 1–2 years. CTC and stool DNA testing were not recommended owing to insufficient evidence.
Conclusion:The 2025 Korean Guidelines for Colorectal Cancer Screening present updated, evidence-based recommendations tailored to the domestic healthcare context. By conditionally endorsing both colonoscopy and FIT for individuals aged 45–74 years, these guidelines aim to improve population-level screening effectiveness and reduce the burden of CRC in South Korea.
